Member access

4-Traders Homepage  >  Shares  >  Xetra  >  CytoTools AG    T5O   DE000A0KFRJ1

CYTOTOOLS AG (T5O)

10
Real-time Quote. Real-time TRADEGATE AG - 05/22 08:00:01 pm
43.5360 EUR   +0.08%
03/11 CYTOTOOLS : Updates on European studies and approval status in India..
2014 CYTOTOOLS : DermaPro
2014 CYTOTOOLS : Clinical development
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
05/18/2015 05/19/2015 05/20/2015 05/21/2015 05/22/2015 Date
44.01(c) 43.88(c) 42.5(c) 43.5(c) 43.205 Last
887 1 625 363 888 3 406 Volume
-3.25% -0.30% -3.14% +2.35% -0.68% Change
More quotes
Financials (€)
Sales 2014 1,94 M
EBIT 2014 -1,74 M
Net income 2014 -0,92 M
Finance 2014 2,50 M
Yield 2014 -
Sales 2015 6,63 M
EBIT 2015 2,68 M
Net income 2015 1,22 M
Finance 2015 1,80 M
Yield 2015 -
PER 2014 -
PER 2015 66,41
EV / Sales 2014 41,3x
EV / Sales 2015 12,2x
Capitalization 82,7 M
More Financials
Company
CytoTools AG operates as a technology and associated company, which is engaged in the purchase, management and sale of shareholdings in German technology enterprises.It focuses on investing in enterprises from the health sector, active in the area of research and development of medicaments and... 
More about the company
Surperformance© ratings of CytoTools AG
Trading Rating : - Investor Rating :
More Ratings
Latest news on CYTOTOOLS AG
07:55a CYTOTOOLS : ernennt Dr. Rüdiger Weseloh von Merck Serono zum Aufsichtsrat (DGAP ..
05/13 CYTOTOOLS : Erfolgreicher Dialog mit der amerikanischen Food and Drug Administra..
05/06 CYTOTOOLS : Patent Issued for Apoptotically Active Peptides
04/15 CYTOTOOLS : Rekrutierung von Patienten für Europäische Studien zum diabetischen ..
03/11 CYTOTOOLS : Updates on European studies and approval status in India.pdf
03/04 CYTOTOOLS : Europäische Studien zum diabetischen Fuß und offenen Bein im Zeitpla..
2014 CYTOTOOLS : DermaPro
2014 CYTOTOOLS : Clinical development
More news
Sector news : Bio Therapeutic Drugs
11:28a SYNAGEVA BIOPHARMA : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investiga..
07:04a BLUEBIRD BIO : Announces Participation at the Jefferies 2015 Global Healthcare C..
05/21 ABBVIE : specifies breakdown of $21 billion Pharmacyclics deal
More sector news : Bio Therapeutic Drugs


Comments 
Advertisement
Chart CYTOTOOLS AG
Duration : Period :
CytoTools AG Technical Analysis Chart | T5O | DE000A0KFRJ1 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions